These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment and outcome of lupus nephritis at the turn of the millennium. Uppal SS J Assoc Physicians India; 1999 Sep; 47(9):857-61. PubMed ID: 10778651 [No Abstract] [Full Text] [Related]
3. [Lupus nephropathy in children]. Fischbach M Arch Pediatr; 2010 Jun; 17(6):628-9. PubMed ID: 20654813 [No Abstract] [Full Text] [Related]
4. [Lupus nephropathy: difficulties in its treatment]. Flores JC Rev Med Chil; 1989 Aug; 117(8):930-6. PubMed ID: 2519456 [TBL] [Abstract][Full Text] [Related]
5. [Morphologically unfavorable forms of lupus glomerulonephritis: treatment and prognosis]. Zakharova EV; Mikhaĭlova NA; Ermolenko VM; Gabdurakhmanov II; Varshavskiĭ VA; Proskurneva EP Ter Arkh; 2003; 75(6):56-60. PubMed ID: 12920962 [No Abstract] [Full Text] [Related]
6. [Corticosteroids administered in bolus in lupus nephropathy]. Smurra G; Quaranta G; Angiello G Ann Ital Med Int; 1986 Mar; 1(1):75-80. PubMed ID: 3275182 [No Abstract] [Full Text] [Related]
8. Lupus nephritis: classification, clinical features, and treatment. Weissleder R; Galarza DA; Garza MA Rev Invest Clin; 1987; 39(3):263-76. PubMed ID: 3324251 [No Abstract] [Full Text] [Related]
9. [Lupus nephritis in Senegal: study of 42 cases]. Dia D; Ka EF; Cissé M; Pouye A; Niang NM; Kane A; Dieng MT; Niang A; Ka MM; Diouf B; Ndiaye B; Moreira-Diop T Dakar Med; 2007; 52(1):23-6. PubMed ID: 19102087 [TBL] [Abstract][Full Text] [Related]
10. [New therapeutics in lupus nephritis]. Fariñas MC; Rodríguez-Valverde V Med Clin (Barc); 1989 Feb; 92(7):258-60. PubMed ID: 2716408 [No Abstract] [Full Text] [Related]
12. Treatment of membranous lupus nephritis: where are we now? Beck LH; Salant DJ J Am Soc Nephrol; 2009 Apr; 20(4):690-1. PubMed ID: 19279123 [No Abstract] [Full Text] [Related]
13. Efficacy of enteric-coated mycophenolate sodium in patients with active lupus nephritis. Mak SK; Lo KY; Lo MW; Chan SF; Tong GM; Wong PN; Wong AK Nephrology (Carlton); 2008 Jun; 13(4):331-6. PubMed ID: 18476916 [TBL] [Abstract][Full Text] [Related]
14. Histologic deterioration and more flares: the case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis. Chan TM Arthritis Rheum; 2007 Mar; 56(3):702-4. PubMed ID: 17328038 [No Abstract] [Full Text] [Related]
15. When a patient with known lupus nephritis has persistent proteinuria despite corticosteroids and immunosuppressive treatment can it be assumed that there is continuing disease activity or may it reflect irreparable glomerular damage? How can one be sure? Cameron JS Br J Rheumatol; 1990 Feb; 29(1):68. PubMed ID: 2306576 [No Abstract] [Full Text] [Related]
17. [Lupus nephritis in the middle of the 20th century and in the beginning of 21st century]. Tareeva IE; Shilov EM; Krasnova TN; Kozlovskaia LV; Shvetsov MIu; Ianushkevich TN; Samokishina NA Ter Arkh; 2001; 73(6):5-10. PubMed ID: 11521523 [No Abstract] [Full Text] [Related]
18. What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials? Clark WF; Sontrop JM Clin J Am Soc Nephrol; 2008 May; 3(3):895-8. PubMed ID: 18287258 [No Abstract] [Full Text] [Related]
20. Early diagnosis and treatment in lupus nephritis: how we can influence the risk for terminal renal failure. Fiehn C J Rheumatol; 2006 Aug; 33(8):1464-6. PubMed ID: 16881102 [No Abstract] [Full Text] [Related] [Next] [New Search]